Security · CUSIP 88339KAA0
THERAVANCE BIOPHARMA INC
NOTE 3.250%11/0 · institutional ownership from 13F filings
13F holders
1
Shares held
0
Value held
$0
New / sold out
0 / 3
Added / reduced
0 / 0
net -16.5M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2022
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Biggest buyers
Nothing to show.
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Maven Securities LTD | Sold out | -14,780,000 | -100.0% |
| Saltoro Capital, LP | Sold out | -1,500,000 | -100.0% |
| Bank of New York Mellon Corp | Sold out | -200,000 | -100.0% |